Strategic Partnerships
Pillar Biosciences is committed to establishing strategic global partnerships that facilitate and enable the adoption of NGS testing at laboratories to improve patient care.
Illumina is Pillar’s non-exclusive global distribution and co-marketing partner for our RUO and IVD kitted product portfolio. Pillar and Illumina have an established IVD development partnership for MiSeqDx and NextSeqDx.
Automation development partnership to support panel automation on Hamilton’s NGS STAR.
CellCarta is a leading global CRO laboratory to the biopharmaceutical industry. Pillar and CellCarta have a strategic partnership to broaden access to fast, operationally streamlined NGS tumor profiling for biopharma sponsors and clinical research partners worldwide.
Want to be the first to know about new
and exciting news at Pillar Biosciences?
Sign up for our mailing list here